Efficacy and toxicity of carfilzomib- or bortezomib-based regimens for treatment of transplant-ineligible patients with newly diagnosed multiple myeloma: A meta-analysis

Multiple myeloma is a clonal disorder of malignant plasma cells that comprises approximately 10% of hematologic malignancies. The aim of this study was to investigate the efficacy and toxicity of carfilzomib- or bortezomib-based regimens for treatment of transplant-ineligible patients with newly dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Chunhong, Wei, Min, Yang, Feiyan, Liu, Qin, Wu, Fuzhen, Huang, Jinxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524967/
https://www.ncbi.nlm.nih.gov/pubmed/36181088
http://dx.doi.org/10.1097/MD.0000000000030715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524967/
https://www.ncbi.nlm.nih.gov/pubmed/36181088
http://dx.doi.org/10.1097/MD.0000000000030715

Ejemplares similares